Out-licensing: Cardiovascular/Acute Coronary Syndromes/Angina

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 1..8 of 8 - per page
Order by

1,2,4-benzothiadiazine derivatives useful for the treatment of endocrinological system diseases such as hyperinsulinaemia and diabetes. More

Generic version of an ultra short acting beta blocker: Esmolol 100mg/10 ml vial

Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More

Vessel Delineation in Magnetic Resonance Angiographic Images

Algorithms and computer-implemented methods for tracking the paths of vessels in magnetic resonance angiography More

Use of LCAT to Reduce Cholesterol and Prevent Atherosclerosis

A method of decreasing accumulation of cholesterol in arteries of humans by administering lecithin-cholesterol acyltransferase (LCAT). More

IMG-001 - MAGNETIC RESONANCE -Sliding Thin Slab Acquisition of MRI Data for MRA- SLINKY

A new excitation pulse sequence for the acquisition of Magnetic Resonance Imaging (MRI) data of particular usefulness in Magnetic Resonance Angiography (MRA). More

IMG-002 - ULTRASOUND -Computer Controlled Positive Displacement Pump for Physiological Blood Flow Simulation

This invention relates to a computer-controlled physiological flow simulator for use in the study of vascular hemodynamics and the calibration of clinical imaging systems used to measure blood flow More

Beta Agonist Compounds Comprising 'NO' Donor and ROS Scavengers for Asthma/Steroid Compounds with 'NO' Donor Activity-OXO55

New substituted phenyl compounds useful for the treatment of respiratory disorders e.g. extrinsic or intrinsic or atopic asthma, chronic bronchitis, bronchiectasis and emphysema - multifunctional ?-agonist compounds comprising a reactive oxygen... More

Method of preparing sustained release Trimetazidine Dihydrochloride composition for the treatment of angina.

Medium sized Indian company owns the patent for the preparation of sustained release Trimetazidine Dihydrochloride composition indicated for the treatment of angina and is now looking for out-licensing partners. More

Displaying 1..8 of 8 - per page
Order by

Your selection

Therapeutic target: Cardiovascular del; Acute coronary syndromes del; Angina del

Browse By

Industry sector: Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Pharmaceutical; Research tools
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us